Relevance of cost-effectiveness analysis to clinicians and policy makers

被引：72
作者：
Detsky, Allan S.
Laupacis, Andreas
机构：
[1] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Hlth Policy, Toronto, ON, Canada
[3] Univ Toronto, Dept Management, Toronto, ON, Canada
[4] Univ Toronto, Dept Evaluat, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[7] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 298卷 / 02期
关键词：
D O I：
10.1001/jama.298.2.221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：221 / 224
页数：5
相关论文
共 15 条
[1]  
ABT CC, 1977, COSTS RISKS BENEFITS, pCH3
[2]   Bias in published cost effectiveness studies: systematic review [J].
Bell, CM ;
Urbach, DR ;
Ray, JG ;
Bayoumi, A ;
Rosen, AB ;
Greenberg, D ;
Neumann, PJ .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7543) :699-701
[3]   COST-EFFECTIVENESS UTILITY ANALYSES - DO CURRENT DECISION RULES LEAD US TO WHERE WE WANT TO BE [J].
BIRCH, S ;
GAFNI, A .
JOURNAL OF HEALTH ECONOMICS, 1992, 11 (03) :279-296
[4]  
*CAN I HLTH INF, 2007, DRUG EXP CAN 1985 20
[5]   A CLINICIAN GUIDE TO COST-EFFECTIVENESS ANALYSIS [J].
DETSKY, AS ;
NAGLIE, IG .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (02) :147-154
[6]  
DETSKY AS, 1994, PHARMACOECONOMICS, V6, P281
[7]   COST-EFFECTIVENESS LEAGUE TABLES - MORE HARM THAN GOOD [J].
DRUMMOND, M ;
TORRANCE, G ;
MASON, J .
SOCIAL SCIENCE & MEDICINE, 1993, 37 (01) :33-40
[8]  
Gold MR, 1996, COST EFFECTIVENESS H
[9]   THE JOURNALS POLICY ON COST-EFFECTIVENESS ANALYSES [J].
KASSIRER, JP ;
ANGELL, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) :669-670
[10]  
LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473
12